UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| Date of Report (Date of earliest event reported) | August 18, 2003 | |
|
|
Targeted Genetics Corporation
| Washington | 0-23930 | 91-1549568 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
||
| 1100 Olive Way, Suite 100, Seattle, Washington | 98101 | |
| (Address of principal executive offices) | (Zip Code) | |
| Registrant’s telephone number, including area code | (206) 623-7612 | |
|
|
Not Applicable
1
| Item 5. Other Events. | ||||||||
| Item 7. Exhibits. | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
Item 5. Other Events.
On August 18, 2003, Targeted Genetics Corporation announced that it exercised a portion of its put right with Biogen, Inc. in the amount of approximately $4.8 million by selling Biogen 2,515,843 shares of common stock. The text of the press release is set forth in Exhibit 99.1 attached to this release and incorporated herein by this reference.
Item 7. Exhibits.
| (a) | Financial statements of business acquired. | ||
| Not applicable. | |||
| (b) | Pro forma financial information. | ||
| Not applicable. | |||
| (c) | Exhibits. |
| Exhibit | ||
| No. | Description | |
| 99.1 | Press Release dated August 18, 2003 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| TARGETED GENETICS CORPORATION | ||
| By: /S/ TODD E. SIMPSON | ||
|
|
||
| Date: August 18, 2003 |
Todd E. Simpson Vice President, Finance and Administration and Chief Financial Officer, Secretary and Treasurer (Principal Financial and Accounting Officer) |
EXHIBIT INDEX
| Exhibit | ||
| No. | Description | |
| 99.1 | Press Release dated August 18, 2003 |